Anthera Pharmaceuticals, Inc. Seeks IPO for Company With No Sales as Offerings Slump

Published: Feb 22, 2010

Bookmark and Share

Bloomberg -- Anthera Pharmaceuticals Inc. plans to raise as much as $69 million in an initial public offering this week, testing whether shareholders can double the value of their investment in a company without sales or profits.

Back to news